Clinical Trial Update: Consolidation Pembrolizumab After Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing consolidation pembrolizumab after chemoradiotherapy in locally advanced nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED